Middle EAST Allogeneic Stem Cell Therapy Industry Growth Report: Key Drivers and Strategic Insights
The Middle EAST Allogeneic Stem Cell Therapy Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including advancements in stem cell research, increasing prevalence of chronic diseases, and rising investments in healthcare infrastructure across the region. ...
0 Commentaires 0 Parts 6 Vue 0 Aperçu
Abistem https://abistem.com